Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 49401-49450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05151822
Virtual Reality in Awake Surgery : Pilot Study VIRAS
NARecruiting
50 participants
Started: May 24, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05394142
A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
PHASE2Recruiting
364 participants
Started: May 24, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor7 locations
NCT05344274
Retinal Blood Flow and Autoregulation
PHASE4Recruiting
90 participants
Started: May 23, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor4 locations
NCT05342454
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
N/ARecruiting
1,720 participants
Started: May 23, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05177055
Sleep in Psychiatric Care (SIP): Treatment for Comorbid Delayed Sleep-Wake Phase Disorder (DSWPD)
NARecruiting
60 participants
Started: May 23, 2022 · Completed: Dec 31, 2027
3 conditions2 sponsors2 locations
NCT05353361
A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer
PHASE2Recruiting
402 participants
Started: May 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05629416
The Communicate Study Partnership
PHASE2Recruiting
340 participants
Started: May 23, 2022 · Completed: Dec 31, 2026
4 conditions6 sponsors4 locations
NCT05327023
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
PHASE1/PHASE2Recruiting
430 participants
Started: May 23, 2022 · Completed: Jul 2, 2029
1 condition1 sponsor1 location
NCT05388370
PASS of Paediatric Patients Initiating Selumetinib
N/ARecruiting
125 participants
Started: May 23, 2022 · Completed: May 23, 2028
1 condition1 sponsor45 locations
NCT05218460
Evaluation of Methodological and Technical DEvelopmeNts to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam on Voluntary Subjects
NARecruiting
720 participants
Started: May 23, 2022 · Completed: May 23, 2027
2 conditions1 sponsor1 location
NCT05128604
Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry.
N/ARecruiting
50 participants
Started: May 23, 2022 · Completed: Sep 24, 2026
3 conditions11 sponsors6 locations
NCT05365646
Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
NARecruiting
350 participants
Started: May 23, 2022 · Completed: Oct 31, 2026
7 conditions2 sponsors1 location
NCT04935853
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
N/ARecruiting
1,350 participants
Started: May 23, 2022 · Completed: Jun 1, 2040
1 condition1 sponsor32 locations
NCT05332262
A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction
N/ARecruiting
500 participants
Started: May 23, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05081401
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
PHASE3Recruiting
1,050 participants
Started: May 23, 2022 · Completed: Dec 1, 2027
3 conditions1 sponsor5 locations
NCT05326581
Optimization of Sequences to Improve the Quality and Comfort of the Magnetic Resonance Imaging Examination
N/ARecruiting
750 participants
Started: May 23, 2022 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05271331
ESP Block Versus Wound Infiltration for Laminectomy
NARecruiting
112 participants
Started: May 23, 2022 · Completed: May 20, 2026
4 conditions1 sponsor1 location
NCT04815356
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
PHASE1Recruiting
27 participants
Started: May 23, 2022 · Completed: Dec 1, 2036
2 conditions1 sponsor1 location
NCT05071079
A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes
NARecruiting
48 participants
Started: May 23, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT04998097
The Role of iTBS in Bipolar II Depression
NARecruiting
60 participants
Started: May 23, 2022 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT05397405
Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome
NARecruiting
180 participants
Started: May 23, 2022 · Completed: May 1, 2026
1 condition1 sponsor2 locations
NCT06115876
Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program
N/ARecruiting
2,000 participants
Started: May 23, 2022 · Completed: May 23, 2027
3 conditions1 sponsor1 location
NCT05428605
In Vitro Immunomodulation in Membranous Nephropathy Relapses
NARecruiting
20 participants
Started: May 23, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05257590
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
PHASE2Recruiting
95 participants
Started: May 23, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor5 locations
NCT05803616
Liquid Biopsy to Enable Diagnostics and Monitoring for Immune-mediated Lymphoproliferative Disorders
N/ARecruiting
20 participants
Started: May 23, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor6 locations
NCT05430373
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
PHASE1Recruiting
31 participants
Started: May 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05534906
The Detection of Small Early Liver Cancer With Natural History Follow up
N/ARecruiting
250 participants
Started: May 23, 2022 · Completed: Jun 30, 2035
1 condition7 sponsors1 location
NCT06111820
Evaluation of Training Curriculum and Service of Improving Access to Community Therapies
NARecruiting
330 participants
Started: May 22, 2022 · Completed: Sep 30, 2024
5 conditions2 sponsors21 locations
NCT05447923
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
NARecruiting
450 participants
Started: May 22, 2022 · Completed: Jun 1, 2030
1 condition1 sponsor1 location
NCT05263804
CoHort of Patients to Identify Biological and Imaging markerS of CardiovascUlar Outcomes in Stroke - HIBISCUS-STROKE II
NARecruiting
500 participants
Started: May 22, 2022 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT05339568
Patient's Whole Process Follow-up Management(HOPE-1)
N/ARecruiting
1,268 participants
Started: May 22, 2022 · Completed: Aug 20, 2030
2 conditions1 sponsor1 location
NCT06777030
Role of Exosomes in Pancreatic Cancer Progression
N/ARecruiting
60 participants
Started: May 22, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
PHASE1Recruiting
200 participants
Started: May 22, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor46 locations
NCT05253911
Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.
N/ARecruiting
300 participants
Started: May 21, 2022 · Completed: May 31, 2027
1 condition2 sponsors2 locations
NCT05698862
Mapping the Impact of Gut Microbiota on Brain and Behavior Through the Lens of GABA
NARecruiting
60 participants
Started: May 21, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05539716
Metabolism and Sleep Apnea Treatment
NARecruiting
100 participants
Started: May 20, 2022 · Completed: Sep 1, 2026
2 conditions2 sponsors1 location
NCT05351476
Exercise Training and Fat Metabolism in Postmenopausal Women
NARecruiting
120 participants
Started: May 20, 2022 · Completed: Apr 30, 2027
3 conditions4 sponsors1 location
NCT06310928
The Effect of Thermal Blanket After Peripheral Artery Surgery
NARecruiting
60 participants
Started: May 20, 2022 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT05312892
Sympathetic Mechanisms in Obesity-Crossover Design
PHASE1/PHASE2Recruiting
12 participants
Started: May 20, 2022 · Completed: Dec 31, 2029
2 conditions1 sponsor1 location
NCT05393804
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
PHASE2Recruiting
32 participants
Started: May 20, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04513288
ICITRU : Randomized Trial of Immunonutrition With L-citrulline in Patients Hospitalized in Intensive Care for Sepsis or Septic Shock
NARecruiting
130 participants
Started: May 20, 2022 · Completed: Nov 20, 2026
2 conditions1 sponsor5 locations
NCT05218447
Dosing of Overground Robotic Gait Training with Functional Outcomes and Neuroplasticity After Spinal Cord Injury
NARecruiting
144 participants
Started: May 20, 2022 · Completed: Sep 14, 2025
1 condition3 sponsors1 location
NCT05324579
Studying the Neuronal Basis of Human Social Cognition
NARecruiting
20 participants
Started: May 20, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT04316546
MK-7075 (Miransertib) in Proteus Syndrome
PHASE2Recruiting
45 participants
Started: May 20, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT05163600
The Acute Cardiorespiratory Response to Blood-flow Restricted Versus Traditional Exercise Training Regimens (CaRe BFR)
NARecruiting
24 participants
Started: May 20, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05593081
Multicenter Study of Fulminant Type 1 Diabetes in China
N/ARecruiting
240 participants
Started: May 20, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor10 locations
NCT04792931
Adult Autoimmune Myopathies (MAIA)
NARecruiting
60 participants
Started: May 20, 2022 · Completed: May 20, 2030
1 condition1 sponsor1 location
NCT06031025
Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
N/ARecruiting
71 participants
Started: May 20, 2022 · Completed: Sep 30, 2025
7 conditions1 sponsor1 location
NCT05192057
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
PHASE4Recruiting
30 participants
Started: May 20, 2022 · Completed: Oct 1, 2026
2 conditions1 sponsor1 location
NCT05479812
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
PHASE1Recruiting
150 participants
Started: May 20, 2022 · Completed: Jul 31, 2026
2 conditions2 sponsors14 locations